Wird geladen...
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Immune checkpoint blockade (ICB) has a limited effect on colorectal cancer, underlining the requirement of co‐targeting the complementary mechanisms. Here, we identified prostaglandin E2 (PGE(2)) receptor 4 (EP4) as the master regulator of immunosuppressive myeloid cells (IMCs), which are the major...
Gespeichert in:
| Veröffentlicht in: | EMBO Mol Med |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7799360/ https://ncbi.nlm.nih.gov/pubmed/33283987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202012798 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|